JP Morgan Jumps Onto Marijuana Stock Bandwagon with GW Pharmaceuticals
The time to buy stock in GW Pharmaceuticals, the UK-based company that produces FDA-approved cannabinoid-based medicines to treat epilepsy and other diseases, was in late 2014, when shares in the company were trading at around $80. Or maybe it was late 2016, when share prices were closer to $40. Or betterContinue Reading